2013 American Transplant Congress
Late Versus Early Biliary Complications after Liver Transplantation
Baylor Annette C. and Harold C. Simmons Transplant Institute, Dallas
IntroductionBiliary complications (BC) cause major morbidity and mortality after liver transplantation (LT). Literature is replete with articles on early BC (less than 1 year post…2013 American Transplant Congress
Intravascular Ultrasound (IVUS) Results of a Randomized Trial of Allomap vs Heart Biopsy in the 1st Year after Heart Transplant
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: The previously published IMAGE trial showed that Allomap blood test (ABT) was non-inferior to the endomyocardial biopsy (EMB) for patients (pts) between 6 mos…2013 American Transplant Congress
Anti-IL-6 Receptor (Anti-IL6R) Treatment Is Effective in Reducing Recall Antibody Responses in Sensitized HLA-A2 Skin Graft Recipients
Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA
Background Sensitization to HLA antigens poses significant obstacles for successful transplantation and increase risk for antibody-mediated rejection (ABMR). IL-6/IL-6R interactions are known to have a…2013 American Transplant Congress
Expedited Liver Allocation in the U.S.: A Critical Analysis
The purpose of this study is to critically analyze the distribution patterns and fate of donor livers that were allocated using an expedited placement (EP)…2013 American Transplant Congress
Foetal Outcomes for Kidney Transplant Recipients
Purpose: Kidney transplantation greatly increases the chance of pregnancy and live birth in women with end stage kidney disease of reproductive age. While maternal outcomes…2013 American Transplant Congress
ABO Antibody Removal of Plasmapheresis (PP) with Intravenous Immunoglobulin (IVIG) before ABO-Incompatible (ABOI) Kidney Transplantation
Background: ABOI kidney transplantation is an inevitable option to overcome organ shortage. Outcome of ABOI grafts improved and became equivalent to compatible grafts. There were…2013 American Transplant Congress
Alpha 1-Antitrypsin (A1AT) Prevents Pulmonary Ischemia Reperfusion Injury in Rats
Purpose: Even though lung transplantation has been the effective treatment for patients with end-stage lung diseases, pulmonary ischemia reperfusion (IR) injury continues to be the…2013 American Transplant Congress
Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients
Background and Aim: Calcineurin inhibitor (CNI) treatment has been implicated for chronic allograft dysfunction in renal transplant recipients. We aimed to investigate the effects of…2013 American Transplant Congress
Comparison of Pharmacokinetics of Once- and Twice-Daily Tacrolimus in Pediatric Kidney Transplant Recipients
Aims: Few data is available regarding the pharmacokinetic (Pk) profile of newly developed modified-release once-daily formulation of tacrolimus (MR-Tac) in children. This study investigated Pk…2013 American Transplant Congress
TIMP-1 Deficiency Promotes p53 Pathway and Impairs Hepatocyte Proliferation in Liver Ischemia Reperfusion Injury
Dumont-UCLA Transplant Center, Los Angeles
Hepatic ischemia/reperfusion injury (IRI) remains a challenge in organ transplantation. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is the major endogenous regulator of matrix metalloproteinase-9 (MMP-9). While…
American Transplant Congress abstracts